BDBM50303052 (S)-N6-(1-(5-fluoropyridin-2-yl)ethyl)-3-methyl-N2-(5-methyl-1H-pyrazol-3-yl)pyrazine-2,6-diamine::CHEMBL576068

SMILES Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)cnc2C)[nH]n1

InChI Key InChIKey=OGOUUWVUPLCXQA-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50303052   

TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303052BDBM50303052((S)-N6-(1-(5-fluoropyridin-2-yl)ethyl)-3-methyl-N2...)
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using 2 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303052BDBM50303052((S)-N6-(1-(5-fluoropyridin-2-yl)ethyl)-3-methyl-N2...)
Affinity DataIC50: 18nMAssay Description:Inhibition of JAK2 using 5 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303052BDBM50303052((S)-N6-(1-(5-fluoropyridin-2-yl)ethyl)-3-methyl-N2...)
Affinity DataIC50: 3.66E+3nMAssay Description:Inhibition of JAK3 using 5 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed